| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-155 |
Sentence |
denotes |
The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway. |
| T1 |
0-155 |
Sentence |
denotes |
The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway. |
| T1 |
0-155 |
Sentence |
denotes |
The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway. |
| TextSentencer_T2 |
156-396 |
Sentence |
denotes |
We previously demonstrated that Siglec-15, a member of the Siglec family of glycan-recognition proteins, is expressed on a subset of macrophages and preferentially recognizes the sialyl-Tn (sTn) antigen, a tumor-associated glycan structure. |
| T2 |
156-396 |
Sentence |
denotes |
We previously demonstrated that Siglec-15, a member of the Siglec family of glycan-recognition proteins, is expressed on a subset of macrophages and preferentially recognizes the sialyl-Tn (sTn) antigen, a tumor-associated glycan structure. |
| T2 |
156-396 |
Sentence |
denotes |
We previously demonstrated that Siglec-15, a member of the Siglec family of glycan-recognition proteins, is expressed on a subset of macrophages and preferentially recognizes the sialyl-Tn (sTn) antigen, a tumor-associated glycan structure. |
| TextSentencer_T3 |
397-538 |
Sentence |
denotes |
In this study, we report on the biological significance of the Siglec-15-mediated interaction between monocytes/macrophages and cancer cells. |
| T3 |
397-538 |
Sentence |
denotes |
In this study, we report on the biological significance of the Siglec-15-mediated interaction between monocytes/macrophages and cancer cells. |
| T3 |
397-538 |
Sentence |
denotes |
In this study, we report on the biological significance of the Siglec-15-mediated interaction between monocytes/macrophages and cancer cells. |
| TextSentencer_T4 |
539-632 |
Sentence |
denotes |
Siglec-15 is expressed on tumor-associated macrophages (TAMs) in various human tumor tissues. |
| T4 |
539-632 |
Sentence |
denotes |
Siglec-15 is expressed on tumor-associated macrophages (TAMs) in various human tumor tissues. |
| T4 |
539-632 |
Sentence |
denotes |
Siglec-15 is expressed on tumor-associated macrophages (TAMs) in various human tumor tissues. |
| TextSentencer_T5 |
633-886 |
Sentence |
denotes |
We further demonstrated that its expression is substantially elevated in macrophage colony-stimulating factor-induced M2-like macrophages, which produced more transforming growth factor-β (TGF-β) in response to sTn-positive cells than to negative cells. |
| T5 |
633-886 |
Sentence |
denotes |
We further demonstrated that its expression is substantially elevated in macrophage colony-stimulating factor-induced M2-like macrophages, which produced more transforming growth factor-β (TGF-β) in response to sTn-positive cells than to negative cells. |
| T5 |
633-886 |
Sentence |
denotes |
We further demonstrated that its expression is substantially elevated in macrophage colony-stimulating factor-induced M2-like macrophages, which produced more transforming growth factor-β (TGF-β) in response to sTn-positive cells than to negative cells. |
| TextSentencer_T6 |
887-1215 |
Sentence |
denotes |
We designed a co-culture model of THP-1 (human monocytic leukemia) cells and H157 (human lung carcinoma) cells mimicking the interaction between monocytes/macrophages and cancer cells that recapitulated the enhanced TGF-β production in Siglec-15 expressing THP-1 cells by the cellular interaction with sTn expressing H157 cells. |
| T6 |
887-1215 |
Sentence |
denotes |
We designed a co-culture model of THP-1 (human monocytic leukemia) cells and H157 (human lung carcinoma) cells mimicking the interaction between monocytes/macrophages and cancer cells that recapitulated the enhanced TGF-β production in Siglec-15 expressing THP-1 cells by the cellular interaction with sTn expressing H157 cells. |
| T6 |
887-1215 |
Sentence |
denotes |
We designed a co-culture model of THP-1 (human monocytic leukemia) cells and H157 (human lung carcinoma) cells mimicking the interaction between monocytes/macrophages and cancer cells that recapitulated the enhanced TGF-β production in Siglec-15 expressing THP-1 cells by the cellular interaction with sTn expressing H157 cells. |
| TextSentencer_T7 |
1216-1324 |
Sentence |
denotes |
The enhanced TGF-β production required a direct interaction between the two cell lines through sialic acids. |
| T7 |
1216-1324 |
Sentence |
denotes |
The enhanced TGF-β production required a direct interaction between the two cell lines through sialic acids. |
| T7 |
1216-1324 |
Sentence |
denotes |
The enhanced TGF-β production required a direct interaction between the two cell lines through sialic acids. |
| TextSentencer_T8 |
1325-1529 |
Sentence |
denotes |
Siglec-15 associates with adaptor protein DNAX activation protein of 12 kDa (DAP12) at the binding determinant Lys(274) in the transmembrane domain and transduces a signal to spleen tyrosine kinase (Syk). |
| T8 |
1325-1529 |
Sentence |
denotes |
Siglec-15 associates with adaptor protein DNAX activation protein of 12 kDa (DAP12) at the binding determinant Lys(274) in the transmembrane domain and transduces a signal to spleen tyrosine kinase (Syk). |
| T8 |
1325-1529 |
Sentence |
denotes |
Siglec-15 associates with adaptor protein DNAX activation protein of 12 kDa (DAP12) at the binding determinant Lys(274) in the transmembrane domain and transduces a signal to spleen tyrosine kinase (Syk). |
| TextSentencer_T9 |
1530-1751 |
Sentence |
denotes |
The enhanced TGF-β secretion was significantly attenuated by Syk inhibitor treatment of THP-1 cells or by substitution of the Siglec-15 Lys(274) to Ala, which disrupts the molecular interaction between Siglec15 and DAP12. |
| T9 |
1530-1751 |
Sentence |
denotes |
The enhanced TGF-β secretion was significantly attenuated by Syk inhibitor treatment of THP-1 cells or by substitution of the Siglec-15 Lys(274) to Ala, which disrupts the molecular interaction between Siglec15 and DAP12. |
| T9 |
1530-1751 |
Sentence |
denotes |
The enhanced TGF-β secretion was significantly attenuated by Syk inhibitor treatment of THP-1 cells or by substitution of the Siglec-15 Lys(274) to Ala, which disrupts the molecular interaction between Siglec15 and DAP12. |
| TextSentencer_T10 |
1752-2040 |
Sentence |
denotes |
These findings indicate that Siglec-15 recognizes the tumoral sTn antigen and transduces a signal for enhanced TGF-β secretion in TAMs and further suggest that Siglec-15 on macrophages may contribute to tumor progression by the TGF-β-mediated modulation of intratumoral microenvironments. |
| T10 |
1752-2040 |
Sentence |
denotes |
These findings indicate that Siglec-15 recognizes the tumoral sTn antigen and transduces a signal for enhanced TGF-β secretion in TAMs and further suggest that Siglec-15 on macrophages may contribute to tumor progression by the TGF-β-mediated modulation of intratumoral microenvironments. |
| T10 |
1752-2040 |
Sentence |
denotes |
These findings indicate that Siglec-15 recognizes the tumoral sTn antigen and transduces a signal for enhanced TGF-β secretion in TAMs and further suggest that Siglec-15 on macrophages may contribute to tumor progression by the TGF-β-mediated modulation of intratumoral microenvironments. |